Open access · US-GOV via ClinicalTrials.gov Clinical trial

Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation

Authors not listed

Vinmec Research Institute of Stem Cell and Gene Technology · 2021

Stem-cell exhaustion Stem-cell therapy Human Randomized controlled trial

Abstract

This trial is to investigate the safety and potential therapeutic efficacy of allogeneic administration of umbilical cord-derived MSCs (UC-MSCs) in combination with standard frailty treatment in Vietnam

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-16 MST

Cite this

APA

Anonymous. (2021). Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation. <em>Vinmec Research Institute of Stem Cell and Gene Technology</em>. https://clinicaltrials.gov/study/NCT04919135

Vancouver

Anonymous. Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation. Vinmec Research Institute of Stem Cell and Gene Technology. 2021.

BibTeX

@misc{anon2021Clinic, title = {Clinical Study of Mesenchymal Stem/Stromal Cell Therapy in Frailty: a Proposed Experimental Design for Therapeutic and Mechanism Investigation}, author = {Anonymous}, journal = {Vinmec Research Institute of Stem Cell and Gene Technology}, year = {2021}, }